Express Scripts (ESRX)

ESRX (NASDAQ:Health Services)
$69.65
neg -0.96
-1.36%
Today's Range: 69.50 - 70.50 | ESRX Avg Daily Volume: 5,127,000
Last Update: 07/31/14 - 4:00 PM EDT
Volume: 5,336,990
YTD Performance: 0.53%
Open: $70.11
Previous Close: $70.61
52 Week Range: $59.20 - $79.37
Oustanding Shares: 773,580,000
Market Cap: 52,046,462,400
6-Month Chart
TheStreet Ratings Grade for ESRX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 13 13
Moderate Buy 2 2 2 2
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.53 1.53 1.50 1.50
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 29.64
Price Earnings Comparisons:
ESRX Sector Avg. S&P 500
29.64 30.40 28.85
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
6.05% 8.73% 30.13%
GROWTH 12 Mo 3 Yr CAGR
Revenue 10.90 1.31 0.32
Net Income 40.80 0.60 0.17
EPS 28.00 0.04 0.01
Earnings for ESRX:
EBITDA 6.00B
Revenue 104.10B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.29 $1.38 $4.88 $5.47
Number of Analysts 12 13 15 16
High Estimate $1.32 $1.40 $4.91 $5.60
Low Estimate $1.27 $1.33 $4.85 $5.30
Prior Year $1.08 $1.12 $4.33 $4.88
Growth Rate (Year over Year) 19.21% 23.42% 12.59% 12.18%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

Stick With What Is Working Real Money Pro($)

Bearish
Jul 30, 2014 | 8:16 AM EDT
ESRX price target lowered from $86 to $80, Jefferies said. Buy rating. Risk of incremental contract turnover.
Bearish
Jul 28, 2014 | 8:19 AM EDT
ESRX reduced its number, UBS said. Lack of major generic launches and generic inflation headwinds. $82 price target and Buy rating.&nbs...
Using the bull put spread in times of volatility.
A lower price means more value for this high-quality stock.
Bullish
Jun 04, 2014 | 8:11 AM EDT
ESRX target was raised to $85 from $80, Leerink Partners said. Company should benefit from a 10-year contract with WellPoint. Outperfor...
Even the best company, when overvalued, can be a bad stock.
But three days like this and valuations will shift again.
Bearish
May 01, 2014 | 8:16 AM EDT
ESRX lowered its numbers, Barclays said. Driven by lingering winter weather effects and contract implementation delays. $83 price targe...

Off the Charts Real Money Pro($)

Apple gaps up on Comcast talks news triggering our $538 entry price.

Columnist Conversations

Volume in the SPY today was nearly double its 50 day average of volume. (The graph at the bottom of the chart ...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
Market got beat like a rented mule today as equities posted their second worst day of the year. Geopolitical ...
down 302 now, at 16577 the dow 30 is unchanged for 2014. roll the media hype!

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.